本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiora Pharmaceuticals

2.65
+0.07002.71%
盤後2.650.00000.00%16:56 EDT
成交量:1.05萬
成交額:2.76萬
市值:1,174.59萬
市盈率:-1.10
高:2.65
開:2.59
低:2.59
收:2.58
52周最高:2.95
52周最低:1.76
股本:443.24萬
流通股本:385.25萬
量比:1.07
換手率:0.27%
股息:- -
股息率:- -
每股收益(TTM):-2.4100
每股收益(LYR):-2.6400
淨資產收益率:-56.36%
總資產收益率:-21.92%
市淨率:0.70
市盈率(LYR):-1.00

資料載入中...

2022/07/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/26

重要事件披露

8-K - Current report
2022/07/21

SEC問詢函

CORRESP [Cover] - Correspondence
2022/07/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/19

SEC問詢函

CORRESP [Cover] - Correspondence
2022/07/19

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/14

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/07/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/06/21

重要事件披露

8-K - Current report
2022/05/31

重要事件披露

8-K - Current report
2022/05/23

重要事件披露

8-K - Current report
2022/05/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/04/26

重要事件披露

8-K - Current report
2022/04/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/23

重要事件披露

8-K - Current report
2022/02/28

重要事件披露

8-K - Current report
2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals